If you liked this article you might like

Depomed Focuses on Flagship Drug Rather Than M&A: CEO
Biotech Movers: Depomed Shares Tank After Losses Get Even Worse
Analysts' Actions -- Allergan, Coach, General Dynamics, Occidental and More
DepoMed, Opioid Makers Fall After Trump's FDA Pick Says America's Drug Addiction Is Out of Control